These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 6964904)

  • 41. The lipoprotein and lipid pattern in xanthomatosis.
    Heiberg A
    Acta Med Scand; 1975 Sep; 198(3):183-95. PubMed ID: 1180126
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Normocholesterolemic xanthomatosis.
    Parker F
    Arch Dermatol; 1986 Nov; 122(11):1253-7. PubMed ID: 3096220
    [No Abstract]   [Full Text] [Related]  

  • 43. Pirifibrate in the treatment of hyperlipoproteinemias: a multicenter study.
    Domingo AJ; Gutiérrez JA; Menéndez JA; Micó L; Muñoz M; de Oya M
    Clin Ther; 1980; 3(3):219-26. PubMed ID: 7459931
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Lipid status in patients on a chronic hemodialysis program].
    Tepsić V; Ristić V; Perunicić G; Rasić Z; Pljesa S; Bokan L; Ranković N
    Med Pregl; 1997; 50(1-2):45-7. PubMed ID: 9132551
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Scalp pain and hyperlipidaemia.
    Aravindan PD; Lloyd-Mostyn RH
    Int J Clin Pract; 2000 Sep; 54(7):478-9. PubMed ID: 11070577
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The effect of micronized fenofibrate on lipid parameters and fibrinogen in heterozygous familial hypercholesterolemia and familial combined hyperlipidemia].
    Ceska R; Sobra J; Kvasnicka J; Procházková R; Kvasilová M; Haas T
    Cas Lek Cesk; 1996 Jul; 135(13):413-6. PubMed ID: 8925538
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Blood lipids and lipoproteins in patients with ischemic heart disease without hyperlipoproteinemia].
    Tokarskaia ZB; Tel'nov VI
    Ter Arkh; 1982; 54(5):43-6. PubMed ID: 7101185
    [No Abstract]   [Full Text] [Related]  

  • 48. Gingival and cutaneous xanthomatosis associated with primary biliary cirrhosis. Report of a case.
    Brooks JK
    Oral Surg Oral Med Oral Pathol; 1990 Dec; 70(6):744-7. PubMed ID: 2263334
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Fibrinolytic capacity after exertion in atherogenic hyperlipoproteinemias].
    Zdrenghea D; Mărcuşu C; Cucuianu M; Rentsch S
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1979; 31(5):435-40. PubMed ID: 44567
    [No Abstract]   [Full Text] [Related]  

  • 50. Non-HDL cholesterol and apoB in dyslipidaemia.
    Sniderman AD; Hogue JC; Bergeron J; Gagné C; Couture P
    Clin Sci (Lond); 2008 Jan; 114(2):149-55. PubMed ID: 17868037
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Apolipoprotein E and activity of cholesterol esters transport in type IIA and IIB hyperlipoproteinemia].
    Tvorogova MG; Rozhkova TA; Semenova OA; Lupanov VP; Nuraliev EIu ; Kukharchuk VV; Titov VN
    Ter Arkh; 1997; 69(12):30-3. PubMed ID: 9503530
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hemorrheologic abnormalities in defined primary dyslipoproteinemias with both high and low atherosclerotic risks.
    Otto C; Ritter MM; Richter WO; Minkenberg R; Schwandt P
    Metabolism; 2001 Feb; 50(2):166-70. PubMed ID: 11229424
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dietary control of hyperlipoproteinemia.
    Lacatîs D; Bălan M; Creţeanu G
    Med Interne; 1980; 18(1):49-53. PubMed ID: 7375800
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinical manifestations of familial hypercholesterolemia in Mediterranean population].
    Alonso-Villaverde C; Sardà P; Vallbé JC; Heras M; Pérez-Jiménez F; Pedro-Botet JC; Ros-Rahola E; Masana L
    Med Clin (Barc); 1999 Oct; 113(14):521-5. PubMed ID: 10605666
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Fenofibrate: hypolipaemic activity and safety in long-term treatment. Effects on HDL, LDL, VLDL and apoprotein B in short-term treatment (author's transl)].
    Rouffy J; Sauvanet JP; Chanu B; Bakir R; Goy-Loeper J; Saya C; Pinaroli F
    Nouv Presse Med; 1980 Dec; 9(49):3747-51. PubMed ID: 7208341
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Low HDL-cholesterol is common in European Type 2 diabetic patients receiving treatment for dyslipidaemia: data from a pan-European survey.
    Bruckert E; Baccara-Dinet M; Eschwege E
    Diabet Med; 2007 Apr; 24(4):388-91. PubMed ID: 17335463
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ocular signs and symptoms of altered blood lipids.
    Alexander LJ
    J Am Optom Assoc; 1983 Feb; 54(2):123-6. PubMed ID: 6841866
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Hyperlipoproteinemias and proteinase inhibitor balance in patients with proliferative diabetic retinopathy with solid exudates in retina].
    Chesnokova NB; Kuznetsova TP; Davydova GA; Grigor'ev AV
    Vestn Oftalmol; 1999; 115(1):14-6. PubMed ID: 10207312
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Hyperlipoprotein phenotypes as risk factors in ischemic cardiopathy. II. Clinical aspects].
    Walter-Rosianu A
    Rev Pediatr Obstet Ginecol Pediatr; 1984; 33(2):145-60. PubMed ID: 6429817
    [No Abstract]   [Full Text] [Related]  

  • 60. [Localization of vessel lesions in arteriosclerosis and blood lipid composition].
    Lipovetskiĭ BM; Vinogradova TV
    Ter Arkh; 2002; 74(2):55-7. PubMed ID: 11899828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.